Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
The companies plan to start a pivotal Phase 3 trial in the coming months
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
Supply readiness follows months of manufacturing to ensure timely and ample supply
Subscribe To Our Newsletter & Stay Updated
